A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

about

Q57803812

sameAs

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

Item

http://www.wikidata.org/entity/Q57803798

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@en

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@nl

type

Item

label

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@en

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@nl

prefLabel

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@en

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@nl

P1476

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

@en

P2093

Alex Vicino

http://www.w3.org/2001/XMLSchema#string

George Coukos

http://www.w3.org/2001/XMLSchema#string

Jaqueline Ghosn

http://www.w3.org/2001/XMLSchema#string

Michel Obeid

http://www.w3.org/2001/XMLSchema#string

Olivier Michielin

http://www.w3.org/2001/XMLSchema#string

P2860

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies).

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale.

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.

The pattern and diagnostic criteria of sensory neuronopathy: a case-control study

Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.

A practical guide to the handling and administration of talimogene laherparepvec in Europe.

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP).

P2888

s40425-018-0429-4

P304

110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S40425-018-0429-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Kuntzer

P577

2018-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30348223

http://www.w3.org/2001/XMLSchema#string

P921

P932

6196470

http://www.w3.org/2001/XMLSchema#string

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

about

sameAs

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932